Physician profile
Katherine Elizabeth Barker
NPI 1073198081
$2,352.26
in general payments reported to CMS, 2019-2025
13 companies · $622 in 2025
The $622 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.78 · 2022: $113 · 2023: $882 · 2024: $717 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,221.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $859.93 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $430.29 | 2022-2025 | Mounjaro, Zepbound, Trulicity |
| Abbvie INC. | $419.73 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $266.99 | 2022-2024 | Xifaxan, Trulance |
| Novo Nordisk INC | $222.79 | 2022-2024 | Ozempic, Rybelsus |
| Incyte Corporation | $42.00 | 2025 | Jakafi, Niktimvo |
| Abiomed | $28.92 | 2025 | |
| Exact Sciences Corporation | $19.45 | 2024 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $16.16 | 2022 | |
| Glaxosmithkline, LLC. | $14.43 | 2023 | Trelegy Ellipta |
| Medtronic, INC. | $13.79 | 2023 | Intellis Adaptivestim |
| Pfizer INC. | $12.93 | 2021 | |
| Genentech USA, INC. | $4.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Barker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.